Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer
{{output}}
Introduction: We aimed to assess acute toxicity and overall survival (OS) in patients with limited-stage small cell lung cancer (LS-SCLC) who received concurrent thoracic chemoradiotherapy using either once-daily (OD) or twice-a-... ...
